STOCK TITAN

Roper Technologies, Inc. Form 4 Filings

ROP NASDAQ

Every Form 4 that Roper Technologies, Inc. (ROP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ROP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ROP filings page.

Rhea-AI Summary

ROPER TECHNOLOGIES INC (symbol: ROP) is the issuer of record for a Form 4 filing submitted to the SEC. Joyce Thomas Patrick JR reported acquisition or exercise transactions in this Form 4 filing.

ROPER TECHNOLOGIES INC (ROP) director Thomas Patrick Joyce Jr. received a grant of 78 restricted shares of Common Stock on September 15, 2026, under the Director Compensation Plan. These restricted shares vest on the 6-month anniversary of the grant date. Following the grant, he holds 5,129 shares directly and 1,400 shares indirectly through a Spousal Trust.

Rhea-AI Summary

ROPER TECHNOLOGIES INC (symbol: ROP) is the issuer of record for a Form 4 filing submitted to the SEC. ESTEVES IRENE M reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies, Inc. (ROP) reported that director Irene M. Esteves received a grant of 78 restricted stock units of common stock on September 15, 2026, as part of the Director Compensation Plan. Each unit represents one share and vests on the 6‑month anniversary of the grant date. Esteves elected to defer receipt under the Company’s Non-Qualified Retirement Plan, and her directly owned common stock holdings are reported as 5,129 shares following this award. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

ROPER TECHNOLOGIES INC (symbol: ROP) is the issuer of record for a Form 4 filing submitted to the SEC. ARCHAMBEAU SHELLYE L reported acquisition or exercise transactions in this Form 4 filing.

ROPER TECHNOLOGIES INC (ROP) reported that director Shellye L. Archambeau received a grant of 84 restricted shares of common stock on September 15, 2026. The shares were granted at $0.00 per share under the Director Compensation Plan and will vest on the six‑month anniversary of the grant date. Following this award, the director directly holds 9,561 shares of Roper Technologies common stock. No Rule 10b5‑1 trading plan is reported for this grant.

Rhea-AI Summary

Roper Technologies executive John K. Stipancich, EVP, Chief Legal Officer & Secretary, exercised 2,000 Employee Stock Options on 27 Jul 2026 at an exercise price of $228.84 per share, receiving 2,000 common shares and eliminating this option position. He then sold 2,000 common shares the same day at a weighted average price of $379.05 per share in multiple trades between $378.93 and $379.35, resulting in a net sale of 2,000 shares reported in this filing.

Rhea-AI Summary

Roper Technologies director Richard F. Wallman reported selling 6,434 shares of common stock on 2026-07-24 at $361 per share in a sale described as an open market or private transaction. After this transaction, he directly holds 7,423 Roper Technologies shares. The filing’s Rule 10b5-1 checkbox was left unchecked.

Rhea-AI Summary

ESTEVES IRENE M reported acquisition or exercise transactions in this Form 4 filing.

ROPER TECHNOLOGIES INC director Irene M. Esteves received an equity award rather than buying shares on the market. She was granted 1,191 restricted share units of Common Stock under the Director Compensation Plan, increasing her directly held shares to 5,051. The filing notes she elected to defer receipt of these restricted stock units under the company’s Non-Qualified Retirement Plan, so the shares will be delivered at a later date as part of her deferred compensation.

Rhea-AI Summary

ARCHAMBEAU SHELLYE L reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Shelleye L. Archambeau received an equity award of 1,191 shares of common stock in the form of restricted stock units. The grant was made at no cash cost to her as director compensation and increases her direct holdings to 9,477 shares.

The restricted stock units vest in two stages: 50% on the six-month anniversary of the grant date and 50% on the day before the 2027 Annual Meeting of Shareholders. This structure encourages ongoing board service and aligns director compensation with long-term shareholder interests rather than short-term trading.

Rhea-AI Summary

Joyce Thomas Patrick JR reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Thomas Patrick Joyce Jr. reported an equity award of restricted stock units under the Director Compensation Plan. He received 1,191 restricted stock units, each representing a contingent right to one share of Roper Technologies common stock.

The award vests in two equal parts: 50% on the six-month anniversary of the grant date and 50% on the day prior to the 2027 Annual Meeting of Shareholders. After this grant, Joyce directly holds 5,051 shares of common stock and has an additional 1,400 shares held indirectly through a spousal trust.

Rhea-AI Summary

BRINKLEY AMY WOODS reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Amy Woods Brinkley received an equity award rather than trading shares. She was granted 1,191 restricted stock units of common stock as director compensation, with no cash paid per unit. After this grant, she directly holds 19,375 shares and units in total.

The restricted stock units are contingent rights to receive one share of Roper common stock for each unit. They vest in two installments: 50% on the 6-month anniversary of the grant date and 50% on the day before the 2027 Annual Meeting of Shareholders, tying the award to ongoing board service.

Rhea-AI Summary

JOHNSON ROBERT D reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Robert D. Johnson received an equity award, increasing his stake in the company. He was granted 1,191 shares of common stock in the form of restricted stock units under the Director Compensation Plan, at no cash cost to him.

The award vests in two stages: 50% on the six-month anniversary of the grant date and the remaining 50% on the day before the 2027 Annual Meeting of Shareholders. After this grant, Johnson directly holds 5,885 shares of Roper Technologies common stock.

Rhea-AI Summary

Murphy John Francis reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director John Francis Murphy received a grant of 1,191 shares of restricted common stock as compensation under the company’s Director Compensation Plan. After this award, he directly holds 2,687 common shares. The restricted shares vest 50% on the 6‑month anniversary of the grant date and 50% on the day before the 2027 Annual Meeting of Shareholders.

Rhea-AI Summary

Thatcher Laura G reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Laura G. Thatcher received a grant of 1,191 restricted common shares under the Director Compensation Plan at no cash cost. The shares vest 50% six months after the grant date and 50% the day before the 2027 Annual Meeting of Shareholders, bringing her direct holdings to 22,115 shares.

Rhea-AI Summary

WALLMAN RICHARD F reported acquisition or exercise transactions in this Form 4 filing.

ROPER TECHNOLOGIES INC reported that director Richard F. Wallman received a grant of 1,191 shares of common stock as restricted shares under the company’s Director Compensation Plan. This is a stock-based compensation award, not an open-market purchase, and was recorded at a price of $0.00 per share.

The restricted shares vest in two stages: 50% on the six-month anniversary of the grant date and 50% on the day prior to the 2027 Annual Meeting of Shareholders. Following this grant, Wallman directly holds 13,857 shares of Roper Technologies common stock.

Rhea-AI Summary

Roper Technologies director Irene M. Esteves received a grant of 85 restricted stock units. These units were awarded as part of the company’s Director Compensation Plan and each unit represents a contingent right to receive one share of Roper Technologies common stock.

The restricted stock units vest on the 6‑month anniversary of the grant date, meaning they must be held for that period before converting into shares. After this award, Esteves is reported as directly owning 3,860 shares of common stock. She has elected to defer receipt of these shares under the company’s Non‑Qualified Retirement Plan.

Rhea-AI Summary

Joyce Thomas Patrick JR reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Thomas Patrick Joyce Jr. reported receiving a grant of 85 shares of common stock as a director compensation award. The shares were granted at no cash cost and are restricted stock that will vest on the six-month anniversary of the grant date. Following this award, he directly holds 3,860 common shares and also reports indirect ownership of 1,400 shares through a spousal trust.

Rhea-AI Summary

ARCHAMBEAU SHELLYE L reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Shellye L. Archambeau received a grant of restricted stock. She was awarded 92 shares of common stock at no cost under the company’s Director Compensation Plan. After this grant, she directly holds 8,286 common shares. The restricted shares vest on the six-month anniversary of the grant date.

Rhea-AI Summary

WALLMAN RICHARD F reported acquisition or exercise transactions in this Form 4 filing.

Roper Technologies director Richard F. Wallman received a grant of 92 shares of Common Stock as restricted stock under the company’s Director Compensation Plan. These restricted shares were awarded at no cash cost and will vest on the six-month anniversary of the grant date.

Following this award, Wallman directly holds a total of 12,666 shares of Roper Technologies common stock. This is a compensation-related equity grant rather than an open-market purchase or sale, so it does not reflect a discretionary trading decision.

Rhea-AI Summary

Roper Technologies VP and Corporate Controller Brandon L. Cross reported equity-based compensation awards and related tax withholding. He received 3,626 employee stock options to buy common shares at $353.87 per share, vesting 50% on March 10, 2028 and 50% on March 10, 2029. He also acquired 972 and 230 shares of common stock as grants, while 110 shares were withheld to cover tax liabilities. Following these transactions, he directly holds 2,271 common shares, plus indirect holdings through a 401(k) plan and an IRA, along with the newly granted options.

Rhea-AI Summary

Roper Technologies President and CEO Laurence Neil Hunn reported a compensation-related equity update. He received an award of 67,495 employee stock options, each giving the right to buy one share of common stock at an exercise price of $353.87 per share, exercisable beginning on March 10, 2029 and expiring on March 10, 2036.

On the same date, 12,854 shares of common stock were disposed of at $353.87 per share to cover tax liabilities, a non-market transaction reported under code F. After these updates, Hunn directly holds 84,457 shares of common stock and 67,495 stock options, and there are 92,808 shares reported as indirectly held through a limited partnership.

Rhea-AI Summary

Roper Technologies EVP and CFO Jason Conley received a new stock option grant and had shares withheld for taxes. On March 10, 2026, he was granted employee stock options covering 26,535 shares of common stock at an exercise price of $353.87 per share, expiring on March 10, 2036.

On the same date, 3,065 shares of common stock were disposed of to cover tax liabilities, a non-market transaction reported with code F. After these events, he directly owned 28,457 common shares and indirectly held 173 shares through 401(k) ownership, indicating the filing reflects compensation and tax withholding rather than open-market trading.

Rhea-AI Summary

Roper Technologies executive vice president, general counsel and secretary John K. Stipancich received an award of 24,494 employee stock options on March 10, 2026. Each option allows him to buy one share of common stock at $353.87 per share, exercisable beginning March 10, 2029 and expiring March 10, 2036. On the same date, 3,198 shares of common stock were disposed of to cover tax obligations, a non-market transaction coded as tax withholding, leaving him with 35,634 common shares held directly after the transactions.

Rhea-AI Summary

Roper Technologies director Joyce Thomas Patrick Jr. reported an indirect acquisition of common stock through a spousal trust. On February 6, 2026, the spousal trust purchased 1,400 Roper shares at a weighted average price of $358.46, in multiple trades between $358.34 and $358.50. Following this transaction, Patrick beneficially owned 1,400 shares indirectly via the spousal trust and 3,775 shares directly.

Rhea-AI Summary

Roper Technologies (ROP) director reported an open‑market purchase of 1,200 shares of common stock at $450.713 on 11/12/2025.

Following the transaction, the director beneficially owns 18,184 shares, held directly. The filing was signed by attorney‑in‑fact John K. Stipancich.

Rhea-AI Summary

Roper Technologies (ROP) reported insider share purchases by its President and CEO (also a Director). On 11/12/2025, the reporting person executed two open‑market transactions coded “P”: 8,000 shares at a weighted average price of $452.395 and 2,000 shares at $451.575.

Following these transactions, the insider reported 97,311 shares held directly and 92,808 shares held indirectly by a limited partnership. A footnote states the 8,000‑share transaction comprised multiple trades between $452.0402 and $452.6551, with the reported figure reflecting a weighted average; detailed trade breakdowns are available upon request.

Rhea-AI Summary

Roper Technologies (ROP) reported insider activity by its President and CEO/Director on 11/11/2025. The executive exercised 30,000 employee stock options at $186.75 and executed multiple open-market sales under a Rule 10b5-1 trading plan tied to an option award expiring November 17, 2025.

Weighted average sale prices were disclosed for several tranches, ranging from $441.973 to $448.3976. Following the transactions, beneficial ownership stands at 87,311 shares direct and 92,808 shares indirect (by limited partnership).